Journal Title
PHARMACEUTICAL RESEARCH

PHARM RES-DORDR

ISSN / eISSN
0724-8741 / 1573-904X
Aims and Scope
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to:

-(pre)formulation engineering and processing-
computational biopharmaceutics-
drug delivery and targeting-
molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)-
pharmacokinetics, pharmacodynamics and pharmacogenetics.
Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
Subject Area

CHEMISTRY, MULTIDISCIPLINARY

PHARMACOLOGY & PHARMACY

CiteScore
6.90 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q1 #49/260
Medicine - Organic Chemistry Q1 #38/197
Medicine - Pharmaceutical Science Q1 #38/171
Medicine - Biotechnology Q2 #80/299
Medicine - Pharmacology Q2 #91/301
Medicine - Molecular Medicine Q2 #69/171
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
CHEMISTRY, MULTIDISCIPLINARY - SCIE Q2
PHARMACOLOGY & PHARMACY - SCIE Q2
H-index
191
Country/Area of Publication
GERMANY
Publisher
Springer US
Publication Frequency
Monthly
Year Publication Started
1984
Annual Article Volume
283
Open Access
NO
Contact
SPRINGER/PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, USA, NY, 10013
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Continuing from above, the submitted content is related to pharmacokinetics. I personally do not consider it to be novel, but there is a substantial amount of content. Both reviewers asked good questions, some of which were indeed difficult to answer. When revising, I maintained a sincere attitude and did not provide any unconvincing answers.
2021-10-16
6.28 submitted
7.15 under review
8.09 major revision
9.05 revision submitted
9.10 under review
10.08 minor revision
10.09 revision submitted
10.15 accept
2021-10-16

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started